Solid Biosciences Inc. financial data

Symbol
SLDB on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
500 Rutherford Avenue, 3 Rd Floor, Charlestown, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Solid Biosciences, LLC (to 1/25/2018)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.09 K % +21.9%
Debt-to-equity 24.5 % -5.74%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.8 M shares +92.9%
Common Stock, Shares, Outstanding 37.8 M shares +93.3%
Entity Public Float 51.5 M USD +11.5%
Common Stock, Value, Issued 38 K USD +90%
Weighted Average Number of Shares Outstanding, Basic 38.2 M shares +95%
Weighted Average Number of Shares Outstanding, Diluted 38.2 M shares +95%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 70.8 M USD -14.8%
General and Administrative Expense 28.3 M USD -2.25%
Operating Income (Loss) -99.1 M USD +12.4%
Nonoperating Income (Expense) 8.84 M USD -60.5%
Income Tax Expense (Benefit) 0 USD
Earnings Per Share, Basic -3.93 USD/shares +52.5%
Earnings Per Share, Diluted -3.93 USD/shares +52.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 118 M USD -28.6%
Cash, Cash Equivalents, and Short-term Investments 206 M USD +11.1%
Assets, Current 214 M USD +12.4%
Property, Plant and Equipment, Net 6.39 M USD -25.7%
Operating Lease, Right-of-Use Asset 26.1 M USD -7.8%
Other Assets, Noncurrent 175 K USD -26.5%
Assets 249 M USD +8.32%
Accounts Payable, Current 1.73 M USD -69.1%
Accrued Liabilities, Current 10.3 M USD -16.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 14.3 M USD -29.3%
Operating Lease, Liability, Noncurrent 22.5 M USD -5.8%
Other Liabilities, Noncurrent 96 K USD
Liabilities 38 M USD -17.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4 K USD -180%
Retained Earnings (Accumulated Deficit) -683 M USD -15.2%
Stockholders' Equity Attributable to Parent 211 M USD +14.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 126 M USD -40.2%
Liabilities and Equity 249 M USD +8.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.2 M USD +10%
Net Cash Provided by (Used in) Financing Activities 107 M USD
Net Cash Provided by (Used in) Investing Activities -38.5 M USD -203%
Common Stock, Shares Authorized 60 M shares 0%
Common Stock, Shares, Issued 37.8 M shares +93.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 43.6 M USD +370%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 119 M USD -28.3%
Deferred Tax Assets, Valuation Allowance 91.7 M USD -43.9%
Deferred Tax Assets, Gross 99 M USD -42.3%
Operating Lease, Liability 24.6 M USD -6.17%
Depreciation 2.58 M USD +7.18%
Payments to Acquire Property, Plant, and Equipment 149 K USD -70.6%
Lessee, Operating Lease, Liability, to be Paid 38.4 M USD -10.2%
Property, Plant and Equipment, Gross 19.4 M USD -0.11%
Operating Lease, Liability, Current 1.69 M USD -9.07%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.11 M USD -2.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.4 M USD -3.89%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.8 M USD -16.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.12 M USD +0.76%
Deferred Tax Assets, Operating Loss Carryforwards 16.6 M USD -76.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.24 M USD +2.94%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 7.12 M USD +1.07%
Interest Expense 95 K USD -21.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%